← Every company

Revelation Biosciences Inc SEC Filings

What Revelation Biosciences Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.

REVB overview →
Filings on file
106
since Jul 29, 2020
Warning signs
15
latest Jan 7, 2025
Last results
Aug 6, 2026
8-K item 2.02
Industry
Pharmaceutical Preparations
SIC 2834

Newest first

Each label is a form type or an 8-K item as filed; each row links to the filing.

FiledWhat it reportsDocument
Aug 19, 2026
Executive or director change
8-K
Read ↗
Aug 6, 2026
Results announced
8-K
Read ↗
Aug 6, 2026
Quarterly report
10-Q
Read ↗
Jul 13, 2026
Material agreement
8-K
Read ↗
Jun 24, 2026
Executive or director changeShareholder vote
8-K
Read ↗
May 7, 2026
Results announced
8-K
Read ↗
May 7, 2026
Quarterly report
10-Q
Read ↗
Mar 19, 2026
Shareholder vote
8-K
Read ↗
Feb 26, 2026
Results announced
8-K
Read ↗
Feb 26, 2026
Annual report
10-K
Read ↗
Jan 29, 2026
Material agreementUnregistered share sale
8-K
Read ↗
Dec 3, 2025
Shareholder vote
8-K
Read ↗
Nov 6, 2025
Results announced
8-K
Read ↗
Nov 6, 2025
Quarterly report
10-Q
Read ↗
Sep 15, 2025
Material agreementUnregistered share sale
8-K
Read ↗
Aug 8, 2025
Results announced
8-K
Read ↗
Aug 8, 2025
Quarterly report
10-Q
Read ↗
Jun 25, 2025
Shareholder vote
8-K
Read ↗
Jun 4, 2025
Material agreement
8-K
Read ↗
May 28, 2025
Executive or director change
8-K
Read ↗
May 20, 2025
Share offering
S-1
Read ↗
May 8, 2025
Results announced
8-K
Read ↗
May 8, 2025
Quarterly report
10-Q
Read ↗
Mar 6, 2025
Results announced
8-K
Read ↗
Mar 6, 2025
Annual report
10-K
Read ↗
Jan 21, 2025
Shareholder vote
8-K
Read ↗
Jan 7, 2025
Delisting notice or listing transfer
8-K
Read ↗
Dec 6, 2024
Material agreementUnregistered share sale
8-K
Read ↗
Nov 8, 2024
Results announced
8-K
Read ↗
Nov 8, 2024
Quarterly report
10-Q
Read ↗
Oct 21, 2024
Delisting notice or listing transfer
8-K
Read ↗
Sep 23, 2024
Quarterly report
10-Q/A
Read ↗
Sep 23, 2024
Quarterly report
10-Q/A
Read ↗
Sep 23, 2024
Annual report
10-K/A
Read ↗
Aug 26, 2024
Material agreementUnregistered share sale
8-K
Read ↗
Aug 19, 2024
Delisting notice or listing transfer
8-K
Read ↗
Aug 9, 2024
Results announced
8-K
Read ↗
Aug 9, 2024
Quarterly report
10-Q
Read ↗
May 16, 2024
Shareholder vote
8-K
Read ↗
May 10, 2024
Results announced
8-K
Read ↗
May 10, 2024
Quarterly report
10-Q
Read ↗
Mar 22, 2024
Results announced
8-K
Read ↗
Mar 22, 2024
Annual report
10-K
Read ↗
Feb 8, 2024
Material agreement
8-K
Read ↗
Jan 22, 2024
Shareholder vote
8-K
Read ↗
Dec 22, 2023
Share offering
S-1
Read ↗
Nov 13, 2023
Results announced
8-K
Read ↗
Nov 9, 2023
Quarterly report
10-Q
Read ↗
Oct 2, 2023
Executive or director change
8-K
Read ↗
Aug 11, 2023
Results announced
8-K
Read ↗
Aug 11, 2023
Quarterly report
10-Q
Read ↗
Aug 11, 2023
Delisting notice or listing transfer
8-K
Read ↗
Jul 14, 2023
Shareholder vote
8-K
Read ↗
May 22, 2023
Results announced
8-K
Read ↗
May 22, 2023
Quarterly report
10-Q
Read ↗
May 15, 2023
Late filing notice
NT 10-Q
Read ↗
Apr 3, 2023
Results announced
8-K
Read ↗
Mar 30, 2023
Annual report
10-K
Read ↗
Feb 13, 2023
Material agreement
8-K
Read ↗
Jan 31, 2023
Shareholder vote
8-K
Read ↗
Jan 13, 2023
Delisting
25-NSE
Read ↗
Dec 21, 2022
Material agreementUnregistered share sale
8-K
Read ↗
Dec 12, 2022
Delisting notice or listing transfer
8-K
Read ↗
Nov 29, 2022
Share offering
S-1
Read ↗
Nov 25, 2022
Delisting notice or listing transfer
8-K
Read ↗
Nov 10, 2022
Results announced
8-K
Read ↗
Nov 10, 2022
Quarterly report
10-Q
Read ↗
Oct 31, 2022
Share offering
S-1
Read ↗
Aug 17, 2022
Results announced
8-K
Read ↗
Aug 15, 2022
Quarterly report
10-Q
Read ↗
Aug 1, 2022
Material agreement
8-K
Read ↗
Jul 13, 2022
Share offering
S-1
Read ↗
Jun 10, 2022
Delisting notice or listing transfer
8-K
Read ↗
May 31, 2022
Share offering
S-1
Read ↗
May 31, 2022
Delisting notice or listing transfer
8-K
Read ↗
May 17, 2022
Results announced
8-K
Read ↗
May 16, 2022
Quarterly report
10-Q
Read ↗
May 6, 2022
Auditor change
8-K
Read ↗
Apr 15, 2022
Annual report
10-K
Read ↗
Mar 31, 2022
Late filing notice
NT 10-K
Read ↗
Jan 28, 2022
Share offering
S-1
Read ↗
Jan 27, 2022
Material agreementUnregistered share sale
8-K
Read ↗
Jan 14, 2022
Executive or director changeAcquisition or sale completedChange in controlUnregistered share sale
8-K
Read ↗
Jan 12, 2022
Shareholder vote
8-K
Read ↗
Dec 23, 2021
Material agreementNew debt
8-K
Read ↗
Oct 29, 2021
Quarterly report
10-Q
Read ↗
Oct 19, 2021
Material agreementNew debt
8-K
Read ↗
Oct 13, 2021
Shareholder vote
8-K
Read ↗
Sep 23, 2021
Material agreementNew debt
8-K
Read ↗
Sep 20, 2021
Merger vote or registration
S-4
Read ↗
Sep 2, 2021
Material agreement
8-K
Read ↗
Aug 23, 2021
Quarterly report
10-Q
Read ↗
Aug 17, 2021
Late filing notice
NT 10-Q
Read ↗
Jun 22, 2021
Quarterly report
10-Q
Read ↗
Jun 16, 2021
Annual report
10-K/A
Read ↗
Jun 16, 2021
Earlier accounts withdrawn
8-K
Read ↗
Jun 1, 2021
Delisting notice or listing transfer
8-K
Read ↗
May 18, 2021
Late filing notice
NT 10-Q
Read ↗
Mar 31, 2021
Annual report
10-K
Read ↗
Mar 5, 2021
Executive or director change
8-K/A
Read ↗
Feb 23, 2021
Executive or director change
8-K
Read ↗
Nov 16, 2020
Quarterly report
10-Q
Read ↗
Oct 19, 2020
Material agreement
8-K
Read ↗
Oct 13, 2020
Material agreementUnregistered share sale
8-K
Read ↗
Oct 13, 2020
Share offering
424B4
Read ↗
Jul 29, 2020
Share offering
S-1
Read ↗

Source: Revelation Biosciences Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.

More on REVB

Related datasets